Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych CASC / OSCEPsychopharmacology — renal and hepatic disease

Psych CASC / OSCE · Psychopharmacology — renal and hepatic disease

Explaining psychotropic choices in CKD and cirrhosis (CASC)

CASC-style communication station: organ-aware lithium safety, NSAID counselling, benzodiazepine HE risk, and CAST-informed shared decision on antidepressants.

communication2 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 58-year-old woman with bipolar disorder (lithium responder), stage 3b CKD (eGFR 42), and compensated cirrhosis asks why her GP stopped ibuprofen, why you will not give ‘normal sleeping tablets’, and whether her new low mood means she ‘needs sertraline like everyone else on dialysis forums’.

Station instructions (candidate)

You have 7 minutes. Explain in plain language why lithium needs kidney monitoring and why anti-inflammatory painkillers can raise lithium levels; why standard sleeping tablets (benzodiazepines) are risky with her liver disease; and how decisions about antidepressants in kidney disease are individualised — including that a major trial (CAST) found sertraline no better than placebo for depression symptoms in non-dialysis CKD, so expectations and non-drug options matter. Do not terrify her into stopping lithium without a plan. Do not promise cure. Check understanding and safety (suicide risk, who to call if confused or very unsteady).[1][2][3][5]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this CASC / OSCE. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Hedayati SS, Gregg LP, Carmody T, et al. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial JAMA, 2017.PMID 29101402
  2. [2]Gitlin M Lithium side effects and toxicity: prevalence and management strategies Int J Bipolar Disord, 2016.PMID 27900734
  3. [3]Grønbæk L, Watson H, Vilstrup H, et al. Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites United European Gastroenterol J, 2018.PMID 29774154
  4. [4]McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis Lancet, 2012.PMID 22265699
  5. [5]Hedayati SS, Yalamanchili V, Finkelstein FO A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease Kidney Int, 2012.PMID 22012131
  6. [6]Telles-Correia D, Barbosa A, Cortez-Pinto H, et al. Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity World J Gastrointest Pharmacol Ther, 2017.PMID 28217372
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousExplaining MAOI diet, washouts and patch options (CASC)Psychopharmacology — monoamine oxidase inhibitorsNextExplaining QTc risk and medicine changes after a near-syncope (CASC)Psychopharmacology — drug interactions and QTc